Close

UPDATE: Brean Capital Assumes Nektar Therapeutics (NKTR) at Buy

September 30, 2016 6:34 AM EDT Send to a Friend
(Updated - September 30, 2016 9:56 AM EDT)

Brean Capital assumed coverage on Nektar Therapeutics (NASDAQ: NKTR) with a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login